Profil
Jacqueline Cossmon worked as a Senior Director of Investor Relations at XenoPort, Inc. and as an Investor Relations Contact at Veracyte, Inc. She later worked as a Senior VP of Investor Relations and Communications at Tricida, Inc. from 2018 to 2022.
Ehemalige bekannte Positionen von Jacqueline Cossmon
| Unternehmen | Position | Ende |
|---|---|---|
| TRICIDA, INC. | Investor Relations Kontakt | 01.01.2022 |
| VERACYTE, INC. | Public Communications Contact | - |
| XENOPORT, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERACYTE, INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
